Hancock Jaffe Laboratories Inc ROIC
Cos'è ROIC di Hancock Jaffe Laboratories Inc?
ROIC di Hancock Jaffe Laboratories Inc è -130.76%
Qual è la definizione di ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC di aziende nel Health Care settore su NASDAQ rispetto a Hancock Jaffe Laboratories Inc
Cosa fa Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Aziende con roic simili a Hancock Jaffe Laboratories Inc
- Alternate Health ha ROIC di -131.22%
- Akari Therapeutics Plc ha ROIC di -131.14%
- Ideanomics Inc ha ROIC di -130.90%
- Claren ha ROIC di -130.90%
- KWESST Micro Systems ha ROIC di -130.86%
- KWESST Micro Systems ha ROIC di -130.86%
- Hancock Jaffe Laboratories Inc ha ROIC di -130.76%
- Tetra Bio-Pharma ha ROIC di -130.74%
- Odyssey Semiconductor Technologies ha ROIC di -130.61%
- G2 Technologies ha ROIC di -130.35%
- T2 Biosystems Inc ha ROIC di -129.43%
- Allena Pharmaceuticals Inc ha ROIC di -129.33%
- Aurum Resources Ltd ha ROIC di -128.63%